Work

1090 Clinical Benefit of Cabazitaxel Plus Prednisone in the Tropic Trial in Men With Metastatic Castration Resistant Prostate Cancer (mcrpc) Who Progressed After Docetaxel-based Treatment

Cites:
Cited by: 3
Related to: 10